Consequently, MAML2 testing as an ancillary diagnostic tool should be reserved for MECs showing unusual histological appearances [38,39], such as the oncocytic variant of MEC, to rule out oncocytoma and oncocytic carcinoma; and the Whartin-like variant and the recently described ciliated MEC variant, to rule out benign developmental cysts and ciliated, HPV-related squamous cell carcinomas [40,41]. This evidence concerns the gene MAML2 and mucoepidermoid carcinoma.